Brochures
Coagulation et fibrinolyse
Génération de thrombine et fibrinolyse
Diagnostic moléculaire
Analyse des aliments et de l'eau
Publications & Posters
ISTH 2019
- FVIII chromogenic assay and variant method for Measuring Emicizumab and FVIII Inhibitor Antibodies in Human Plasma
- Improved specificity and performances of a novel photometric automated assay for Factor XIII activity
- Neutralization of heparin interferences in DOACs' measurement with Anti Xa chromogenic assays
- New, highly sensitive and specific multiplatform latex automated turbidimetric assay for measurement of Free Protein S in plasma
- Measurement of Anti-FIIa activity of Bivalirudin in plasma with clotting and chromogenic assays
- Bio-Assays for the measurement of Anti-FXa activity of Edoxaban and its metabolites in plasma
DOACs
- Measurement of the Pharmacodynamic Effect of Dabigatran: Thrombin Clotting Time, Stangier et al. 2009
- Dabigatran calibrator and control plasmas for drug measurement in plasma, when required. Amiral et al. 2011
- Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma. Antovic et al. 2013
- New assays for measuring direct thrombin inhibitors in plasma. Peyrafitte et al. 2009
- Specific and Rapid Measurement of Rivaroxaban in Plasma using a New, Dedicated, Chromogenic Assay, Samama et al.